Back to search
FDAFDA · Food and drugs·Recall number D-1091-2014

Alprazolam Extended-Release Tablets, USP, 3 mg, 60-count tablets per bottle, Rx only, Manufactured by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-3086-06, UPC 3 0228-3086-06 2.

Published March 12, 2014 · Recall initiated: February 4, 2014

Summary

FDA records drug Class II recall D-1091-2014, published March 12, 2014 and initiated February 4, 2014. Recalling firm: Actavis Elizabeth LLC; Status: Terminated; Reported quantity: 5,148 bottles; Lot: Lot #: 57617531, Exp 03/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Product did not meet specification requirements for dissolution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis Elizabeth LLC
Distributor
Nationwide
Lot
Lot #: 57617531, Exp 03/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Alprazolam Extended-Release Tablets, USP, 3 mg, 60-count tablets per bottle, Rx only, Manufactured by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-3086-06, UPC 3 0228-3086-06 2. recalled?

Yes. FDA published recall D-1091-2014 on March 12, 2014. Reported hazard: Failed Dissolution Specifications: Product did not meet specification requirements for dissolution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter